In this study, we demonstrated that NANOG expression in tumor cells provoked the immune-refractory feature in the TME by simultaneously disrupting various steps of the antitumor immunity cycle, such as T cell infiltration into tumors and T cell–mediated killing of tumor cells, in an HDAC1-dependent manner. This evidence concerns the gene NANOG and neoplasm.